Merck & Co., Inc.·4

Feb 6, 4:15 PM ET

Oosthuizen Johannes Jacobus 4

4 · Merck & Co., Inc. · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Merck (MRK) President U.S. Market Johannes Oosthuizen Sells 15,000 Shares

What Happened

  • Johannes Jacobus Oosthuizen, President, U.S. Market at Merck & Co., Inc. (MRK), sold 15,000 shares of Merck common stock in open-market transactions on February 6, 2026. The weighted-average price was $121.87 per share (range $121.82–$121.95), for total proceeds of approximately $1,827,992. This was a sale (not a purchase or option exercise).

Key Details

  • Transaction date: 2026-02-06
  • Transaction type/code: Open-market sale (S)
  • Shares sold: 15,000
  • Weighted-average price reported: $121.87; reported range: $121.8200–$121.9500 (see footnote F1)
  • Proceeds: ~$1,827,992
  • Shares owned after transaction: Not disclosed in the provided filing excerpt
  • Footnote: F1 notes the price is a weighted average covering multiple trades and the reporting person will provide a per-price breakdown on request to Merck, any shareholder, or the SEC
  • Timeliness: Filing date and period of report are both 2026-02-06 — no indication in this filing of a late report

Context

  • This was an open-market sale (routine disposition) and does not by itself indicate insider sentiment about Merck. No 10b5-1 plan, option exercise, gift, or tax-withholding event is disclosed in the provided excerpt.

Insider Transaction Report

Form 4
Period: 2026-02-06
Oosthuizen Johannes Jacobus
President, U.S. Market
Transactions
  • Sale

    Common Stock

    [F1]
    2026-02-06$121.87/sh15,000$1,827,99221,197.389 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.8200 to $121.9500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen|2026-02-06

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT